U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Resectable Renal Cell Carcinoma

MedGen UID:
1658628
•Concept ID:
C4743637
•
Neoplastic Process

Definition

Renal cell carcinoma that is amenable to surgical resection. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVResectable Renal Cell Carcinoma

Professional guidelines

PubMed

Surgical and focal treatment for metastatic renal cell carcinoma: A literature review.
Naito S, Kato T, Tsuchiya N
Int J Urol 2022 Jun;29(6):494-501. Epub 2022 Mar 26 doi: 10.1111/iju.14841. PMID: 35340081
Consideration in the management of renal cell carcinoma during the COVID-19 Pandemic.
Zequi SC, Abreu D
Int Braz J Urol 2020 Jul;46(suppl.1):69-78. doi: 10.1590/S1677-5538.IBJU.2020.S108. PMID: 32549075Free PMC Article
Surgical management of metastatic renal cell carcinoma.
Ball MW
Discov Med 2017 Jun;23(129):379-387. PMID: 28877449

Recent clinical studies

Etiology

Comparison of peri- and intraoperative outcomes of open vs robotic-assisted partial nephrectomy for renal cell carcinoma: a propensity-matched analysis.
Hoeh B, Wenzel M, Eckart O, Fleisgarten F, Garcia CC, Köllermann J, Würnschimmel C, Larcher A, Karakiewicz P, Kluth LA, Chun FKH, Mandel P, Becker A
World J Surg Oncol 2023 Jun 22;21(1):189. doi: 10.1186/s12957-023-03061-2. PMID: 37349748Free PMC Article
Adrenal metastases in 1635 patients with renal cell carcinoma: outcome and indication for adrenalectomy.
Siemer S, Lehmann J, Kamradt J, Loch T, Remberger K, Humke U, Ziegler M, Stöckle M
J Urol 2004 Jun;171(6 Pt 1):2155-9; discussion 2159. doi: 10.1097/01.ju.0000125340.84492.a7. PMID: 15126776
Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses.
Rybicki FJ, Shu KM, Cibas ES, Fielding JR, vanSonnenberg E, Silverman SG
AJR Am J Roentgenol 2003 May;180(5):1281-7. doi: 10.2214/ajr.180.5.1801281. PMID: 12704038
Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.
Messing EM, Manola J, Wilding G, Propert K, Fleischmann J, Crawford ED, Pontes JE, Hahn R, Trump D; Eastern Cooperative Oncology Group/Intergroup trial
J Clin Oncol 2003 Apr 1;21(7):1214-22. doi: 10.1200/JCO.2003.02.005. PMID: 12663707
Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control.
Van Poppel H, Bamelis B, Oyen R, Baert L
J Urol 1998 Sep;160(3 Pt 1):674-8. doi: 10.1016/S0022-5347(01)62751-4. PMID: 9720519

Diagnosis

Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses.
Rybicki FJ, Shu KM, Cibas ES, Fielding JR, vanSonnenberg E, Silverman SG
AJR Am J Roentgenol 2003 May;180(5):1281-7. doi: 10.2214/ajr.180.5.1801281. PMID: 12704038

Therapy

Comparison of peri- and intraoperative outcomes of open vs robotic-assisted partial nephrectomy for renal cell carcinoma: a propensity-matched analysis.
Hoeh B, Wenzel M, Eckart O, Fleisgarten F, Garcia CC, Köllermann J, Würnschimmel C, Larcher A, Karakiewicz P, Kluth LA, Chun FKH, Mandel P, Becker A
World J Surg Oncol 2023 Jun 22;21(1):189. doi: 10.1186/s12957-023-03061-2. PMID: 37349748Free PMC Article
Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease.
Wu FTH, Xu P, Chow A, Man S, Krüger J, Khan KA, Paez-Ribes M, Pham E, Kerbel RS
Br J Cancer 2019 Jan;120(2):196-206. Epub 2018 Nov 30 doi: 10.1038/s41416-018-0297-1. PMID: 30498230Free PMC Article
Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.
Messing EM, Manola J, Wilding G, Propert K, Fleischmann J, Crawford ED, Pontes JE, Hahn R, Trump D; Eastern Cooperative Oncology Group/Intergroup trial
J Clin Oncol 2003 Apr 1;21(7):1214-22. doi: 10.1200/JCO.2003.02.005. PMID: 12663707
Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control.
Van Poppel H, Bamelis B, Oyen R, Baert L
J Urol 1998 Sep;160(3 Pt 1):674-8. doi: 10.1016/S0022-5347(01)62751-4. PMID: 9720519

Prognosis

Comparison of peri- and intraoperative outcomes of open vs robotic-assisted partial nephrectomy for renal cell carcinoma: a propensity-matched analysis.
Hoeh B, Wenzel M, Eckart O, Fleisgarten F, Garcia CC, Köllermann J, Würnschimmel C, Larcher A, Karakiewicz P, Kluth LA, Chun FKH, Mandel P, Becker A
World J Surg Oncol 2023 Jun 22;21(1):189. doi: 10.1186/s12957-023-03061-2. PMID: 37349748Free PMC Article
Adrenal metastases in 1635 patients with renal cell carcinoma: outcome and indication for adrenalectomy.
Siemer S, Lehmann J, Kamradt J, Loch T, Remberger K, Humke U, Ziegler M, Stöckle M
J Urol 2004 Jun;171(6 Pt 1):2155-9; discussion 2159. doi: 10.1097/01.ju.0000125340.84492.a7. PMID: 15126776
Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses.
Rybicki FJ, Shu KM, Cibas ES, Fielding JR, vanSonnenberg E, Silverman SG
AJR Am J Roentgenol 2003 May;180(5):1281-7. doi: 10.2214/ajr.180.5.1801281. PMID: 12704038
Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.
Messing EM, Manola J, Wilding G, Propert K, Fleischmann J, Crawford ED, Pontes JE, Hahn R, Trump D; Eastern Cooperative Oncology Group/Intergroup trial
J Clin Oncol 2003 Apr 1;21(7):1214-22. doi: 10.1200/JCO.2003.02.005. PMID: 12663707
Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control.
Van Poppel H, Bamelis B, Oyen R, Baert L
J Urol 1998 Sep;160(3 Pt 1):674-8. doi: 10.1016/S0022-5347(01)62751-4. PMID: 9720519

Clinical prediction guides

Comparison of peri- and intraoperative outcomes of open vs robotic-assisted partial nephrectomy for renal cell carcinoma: a propensity-matched analysis.
Hoeh B, Wenzel M, Eckart O, Fleisgarten F, Garcia CC, Köllermann J, Würnschimmel C, Larcher A, Karakiewicz P, Kluth LA, Chun FKH, Mandel P, Becker A
World J Surg Oncol 2023 Jun 22;21(1):189. doi: 10.1186/s12957-023-03061-2. PMID: 37349748Free PMC Article
Adrenal metastases in 1635 patients with renal cell carcinoma: outcome and indication for adrenalectomy.
Siemer S, Lehmann J, Kamradt J, Loch T, Remberger K, Humke U, Ziegler M, Stöckle M
J Urol 2004 Jun;171(6 Pt 1):2155-9; discussion 2159. doi: 10.1097/01.ju.0000125340.84492.a7. PMID: 15126776
Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses.
Rybicki FJ, Shu KM, Cibas ES, Fielding JR, vanSonnenberg E, Silverman SG
AJR Am J Roentgenol 2003 May;180(5):1281-7. doi: 10.2214/ajr.180.5.1801281. PMID: 12704038
Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.
Messing EM, Manola J, Wilding G, Propert K, Fleischmann J, Crawford ED, Pontes JE, Hahn R, Trump D; Eastern Cooperative Oncology Group/Intergroup trial
J Clin Oncol 2003 Apr 1;21(7):1214-22. doi: 10.1200/JCO.2003.02.005. PMID: 12663707

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...